SCHEMBL19975705

SCHEMBL19975705

Cc1nc2c(c(=O)n(CCCCC(=O)N(C)CO)c(=O)n2C)n1C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TNF P01375 7/20 0.49
▸ LMNA P02545 4/20 0.45
▸ CYP1A2 P05177 2/20 0.45
▸ NFKB1 P19838 2/20 0.45
▸ ACHE P22303 2/20 0.45
▸ PDE4A P27815 2/20 0.45
▸ PMP22 Q01453 2/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ USP2 O75604 1/20 0.45
▸ TSHR P16473 1/20 0.45
▸ ADORA2B P29275 1/20 0.45
▸ PDE4B Q07343 1/20 0.45
▸ PDE4C Q08493 1/20 0.45
▸ PDE4D Q08499 1/20 0.45
▸ RXFP1 Q9HBX9 1/20 0.45
▸ ESR1 P03372 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ BLM P54132 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.39
▸ KDM4E B2RXH2 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6876903 0.89 TNF (0.45) TNFLMNACYP1A2NFKB1ACHE
SCHEMBL6879047 0.84 TNF (0.43) TNFLMNACYP1A2NFKB1ACHE
SCHEMBL8060268 0.83 TNF (0.63) TNFLMNACYP1A2NFKB1ACHE
SCHEMBL6876740 0.81 TNF (0.41) TNFLMNACYP1A2NFKB1ACHE
SCHEMBL6877852 0.81 ADORA2B (0.71) TNFLMNACYP1A2NFKB1ACHE
SCHEMBL6880028 0.79 TNF (0.56) TNFLMNACYP1A2NFKB1ACHE
SCHEMBL6878129 0.77 ADORA2B (0.62) TNFLMNACYP1A2NFKB1ACHE
SCHEMBL6878419 0.77 TNF (0.49) TNFLMNACYP1A2NFKB1ACHE
SCHEMBL13695581 0.76 TNF (0.47) TNFLMNACYP1A2NFKB1ACHE
SCHEMBL15471352 0.76 TNF (0.48) TNFLMNACYP1A2NFKB1ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9918987-B2 Substituted xanthine derivatives CONCERT PHARMACEUTICALS, INC. (US) 2018-03-20 — — US disclosed
Send feedback